NASDAQ: SMLRSemler Scientific Inc Stock
$29.64-0.99 (-3.23%)
Updated Aug 29, 2025
SMLR Price
$29.64
Fair Value Price
$49.88
Market Cap
$438.81M
52 Week Low
$21.77
52 Week High
$81.56
P/E
7.9x
P/B
1.14x
P/S
10.57x
PEG
0.96x
Dividend Yield
N/A
Revenue
$42.98M
Earnings
$37.05M
Gross Margin
90.8%
Operating Margin
108.74%
Profit Margin
86.2%
Debt to Equity
0.36
Operating Cash Flow
$12M
Beta
1.53
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
SMLR Overview
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SMLR's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important SMLR news, forecast changes, insider trades & much more!
SMLR News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SMLR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SMLR ($29.64) is undervalued by 40.58% relative to our estimate of its Fair Value price of $49.88 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SMLR ($29.64) is significantly undervalued by 40.58% relative to our estimate of its Fair Value price of $49.88 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
SMLR ($29.64) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SMLR due diligence checks available for Premium users.
Valuation
SMLR fair value
Fair Value of SMLR stock based on Discounted Cash Flow (DCF)
Price
$29.64
Fair Value
$49.88
Undervalued by
40.58%
SMLR ($29.64) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SMLR ($29.64) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SMLR ($29.64) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SMLR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
7.9x
Industry
32.17x
Market
35.25x
SMLR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SMLR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
SMLR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.14x
Industry
4.07x
SMLR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SMLR price to earnings growth (PEG)
For valuing profitable companies with growth potential
SMLR is good value based... subscribe to Premium to read more.
PEG Value Valuation
SMLR's financial health
Profit margin
Revenue
$8.2M
Net Income
$66.9M
Profit Margin
814.6%
SMLR's Earnings (EBIT) of $46.73M... subscribe to Premium to read more.
Interest Coverage Financials
SMLR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$522.6M
Liabilities
$139.2M
Debt to equity
0.36
SMLR's short-term liabilities ($36.77M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SMLR's long-term liabilities ($102.42M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SMLR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
SMLR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$514.0k
Investing
-$149.7M
Financing
$152.9M
SMLR's operating cash flow ($12.46M)... subscribe to Premium to read more.
Debt Coverage Financials
SMLR vs Medical Device Stocks
Semler Scientific Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.